Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 13, Issue 8, 1998, Pages 1984-1990

  Endo, Morito ^a   Ohi, Hiroyuki ^a   Ohsawa, Isao ^a   Fujita, Takayuki ^a   Matsushita, Misao ^b   Fujita, Teizo ^b  

^a NIHON UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Complement; IgA nephropathy; Mannose binding lectin; Mannose binding lectin associated serine protease

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3C; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C9; CREATININE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MANNOSE BINDING PROTEIN; SERINE PROTEINASE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HEMATURIA; HOST RESISTANCE; HUMAN; HUMAN TISSUE; IMMUNE COMPLEX DEPOSITION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA;

ADOLESCENT; ADULT; ANTIGEN-ANTIBODY COMPLEX; CARRIER PROTEINS; COLLECTINS; COMPLEMENT ACTIVATION; COMPLEMENT MEMBRANE ATTACK COMPLEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY GLOMERULUS; MALE; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; SERINE ENDOPEPTIDASES;

EID: 0031822961     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.8.1984     Document Type: Article

References (25)

1. Van Es LA. Pathogenesis of IgA nephropathy. Kidney Int 1992; 41: 1720-1729
2. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 245: 709-727
3. Galla JH. IgA nephropathy. Kidney Int 1995; 47: 377 387
4. Lee SMK, Rao VM, Franklin WA et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 1982; 13: 314-322
5. Ibels LS, Györy AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine 1994; 73: 79-102
6. Rodicio JL. Idiopathic IgA nephropathy. Kidney Int 1984; 25: 717-729
7. Emancipator SN, Lamm ME. IgA nephropathy: pathogenesis of the most common form of glomerulonephritis. Lab Invest 1989; 60: 168-183
8. Miyazaki R, Kuroda M, Akiyama T, Otani I, Tofuku Y, Takeda R. Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy. Clin Nephrol 1984; 21: 335 340
9. Wyatt RJ, Kanayama Y, Julian BA et al. Complement activation in IgA nephropathy. Kidney Int 1987; 31: 1019-1023
10. Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel Cls-like serine protease. J Exp Med 1992; 176: 1492-1502
11. Sato T, Endo Y, Matsushita M, Fujita T. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein. Int Immunol 1994; 6: 665-669
12. Thiel S, Vorup-Jensen T, Stover CM et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997; 386: 506-510
13. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532-540
14. Andreoli SP, Bergstein JM. Treatment of severe IgA nephropathy in children. Pediatr Nephrol 1989; 3: 248-253
15. Matsushita M, Takahashi A, Hatsuse H, Kawakami M, Fujita T. Human mannose-binding protein is identical to a component of Ra-reactive factor. Biochem Biophys Res Commun 1992; 183: 645-651
16. Terai I, Kobayashi K, Matsushita M, Fujita T, Matsuno K. α2-Macroglobulin binds to and inhibits mannose-binding protein-associated serine protease. Int Immunol 1995; 7: 1579-1584
17. Endoh M, Yamashina M, Ohi H et al. Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues. Clin Exp Immunol 1993; 94: 182-188
18. Matsushita M, Fujita T. Cleavage of the third component of complement (C3) by mannose-binding protein associsted serine protease (MASP) with subsequent complement activation. Immunobiol 1995; 194: 443-448
19. Suzuki S, Nakatomi Y, Sato H, Tsukada H, Arakawa M. Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet 1994; 343: 12-20
20. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nature Med 1995; 1: 237 243
21. Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 1993; 104: 172-182
22. Alien AC, Harper SJ, Feehally J. Galactosylation of N-and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995; 100: 470-474
23. Summerfield JA, Ryder S, Sumiya M et al. Mannose-binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995; 345: 886-889
24. Garred P, Madsen HO, Hofmann B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet 1995; 346: 941-943
25. Thomas HC, Foster GR, Sumiya M et al. Mutation of gene for mannose-binding protein associated with chronic hepatitis B viral infection. Lancet 1996; 348: 1417-1419